CurrentEndo
Get Weekly

Topic · page 11 of 12

Lipids & metabolic liver disease

Lipid disorders and metabolic dysfunction-associated steatotic (fatty) liver disease, as published in the endocrine journals

Briefs 401–440 of 460 placed here, newest publication first

Briefs in Lipids & metabolic liver disease

Newest publication first

  1. Lancet Diabetes Endocrinol

    Lipoprotein(a) and carotid intima-media thickness in children with familial hypercholesterolaemia in the Netherlands: a 20-year follow-up study

    Cohort study

  2. Int J Obes (Lond)

    Lean Indian patients with non-alcoholic fatty liver disease (NAFLD) have less metabolic risk factors but similar liver disease severity as non-lean patients with NAFLD

    Cohort study

  3. J Clin Endocrinol Metab

    Nonalcoholic Fatty Liver Disease Incidence and Remission and Their Predictors During 7 Years of Follow-up Among Finns

    Cohort study

  4. J Clin Endocrinol Metab

    Growth Hormone Administration Improves Nonalcoholic Fatty Liver Disease in Overweight/Obesity: A Randomized Trial

    Randomized controlled trial

  5. Obesity (Silver Spring)

    A low‐energy total diet replacement program demonstrates a favorable safety profile and improves liver disease severity in nonalcoholic steatohepatitis

    Research article

  6. Eur J Endocrinol

    Antagonic effect of ghrelin and LEAP-2 on hepatic stellate cell activation and liver fibrosis in obesity-associated nonalcoholic fatty liver disease

    Mechanistic study

  7. Cardiovasc Diabetol

    The predictive value of atherogenic index of plasma for cardiovascular outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention with LDL-C below 1.8mmol/L

    Cohort study

  8. Eur J Endocrinol

    Mendelian randomisation reveals Sodium-glucose Cotransporter-1 inhibition's potential in reducing Non-Alcoholic Fatty Liver Disease risk

    Research article

  9. Cardiovasc Diabetol

    Association of dynamic change of triglyceride-glucose index during hospital stay with all-cause mortality in critically ill patients: a retrospective cohort study from MIMIC IV2.0

    Cohort study

  10. Cardiovasc Diabetol

    Association between triglyceride-glucose index and all-cause mortality in critically ill patients with ischemic stroke: analysis of the MIMIC-IV database

    Cohort study

  11. J Clin Endocrinol Metab

    The Presence and Severity of NAFLD are Associated With Cognitive Impairment and Hippocampal Damage

    Cross-sectional study

  12. J Clin Endocrinol Metab

    Associations of Macronutrients Intake With MRI-determined Hepatic Fat Content, Hepatic Fibroinflammation, and NAFLD

    Cross-sectional study

  13. Cardiovasc Diabetol

    Association between triglyceride-glucose index trajectories and carotid atherosclerosis progression

    Cohort study

  14. Diabet Med

    Non‐fasting lipids and cardiovascular disease in those with and without diabetes in Alberta's Tomorrow Project: A prospective cohort study

    Cohort study

  15. Cardiovasc Diabetol

    The atherogenic index of plasma and carotid atherosclerosis in a community population: a population-based cohort study in China

    Cohort study

  16. Diabetes Res Clin Pract

    Remnant cholesterol has a non-linear association with non-alcoholic fatty liver disease

    Cross-sectional study

  17. Cardiovasc Diabetol

    U-shaped association between the triglyceride–glucose index and atrial fibrillation incidence in a general population without known cardiovascular disease

    Cohort study

  18. J Clin Endocrinol Metab

    Remnant Cholesterol Independently Predicts the Development of Nonalcoholic Fatty Liver Disease

    Cohort study

  19. Cardiovasc Diabetol

    Association between triglyceride glucose index and arterial stiffness and coronary artery calcification: a systematic review and exposure-effect meta-analysis

    Meta-analysis

  20. Cardiovasc Diabetol

    Association between the triglyceride glucose index and in-hospital and 1-year mortality in patients with chronic kidney disease and coronary artery disease in the intensive care unit

    Cohort study

  21. Cardiovasc Diabetol

    Association between the triglyceride-glucose index and the presence and prognosis of coronary microvascular dysfunction in patients with chronic coronary syndrome

    Cohort study

  22. J Clin Endocrinol Metab

    Effect of Simvastatin Treatment on Mitochondrial Function and Inflammatory Status of Human White Adipose Tissue

    Cross-sectional study

  23. Cardiovasc Diabetol

    The synergistic effect of the triglyceride-glucose index and serum uric acid on the prediction of major adverse cardiovascular events after coronary artery bypass grafting: a multicenter retrospective cohort study

    Cohort study

  24. J Clin Endocrinol Metab

    Increased GH/IGF-I Axis Activity Relates to Lower Hepatic Lipids and Phosphor Metabolism

    Cross-sectional study

  25. Obesity (Silver Spring)

    Rising NAFLD and metabolic severity during the Sars‐CoV‐2 pandemic among children with obesity in the United States

    Cross-sectional study

  26. Diabetes Res Clin Pract

    Noninvasive identification of probable fibrotic nonalcoholic steatohepatitis across the spectrum of glucose tolerance in the United States

    Cross-sectional study

  27. Lancet

    Bariatric–metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial

    Randomized controlled trial

  28. Cardiovasc Diabetol

    Long- and very long-chain ceramides are predictors of acute kidney injury in patients with acute coronary syndrome: the PEACP study

    Cohort study

  29. Cardiovasc Diabetol

    Triglyceride-glucose index, symptomatic intracranial artery stenosis and recurrence risk in minor stroke patients with hypertension

    Cohort study

  30. Cardiovasc Diabetol

    Predicting long-term prognosis after percutaneous coronary intervention in patients with new onset ST-elevation myocardial infarction: development and external validation of a nomogram model

    Cohort study

  31. Diabetes Care

    High Prevalence of NASH and Advanced Fibrosis in Type 2 Diabetes: A Prospective Study of 330 Outpatients Undergoing Liver Biopsies for Elevated ALT, Using a Low Threshold

    Cohort study

  32. Obesity (Silver Spring)

    Causal effect of adiposity on the risk of 19 gastrointestinal diseases: a Mendelian randomization study

    Research article

  33. Obesity (Silver Spring)

    Association of polycyclic aromatic hydrocarbons with systemic inflammation and metabolic syndrome and its components

    Cross-sectional study

  34. J Clin Endocrinol Metab

    Central Sensitivity to Free Triiodothyronine With MAFLD and Its Progression to Liver Fibrosis in Euthyroid Adults

    Cross-sectional study

  35. Cardiovasc Diabetol

    Changes in high-density lipoprotein cholesterol with risk of Cardiovascular Disease among initially high-density lipoprotein-high participants

    Cohort study

  36. Diabetes Res Clin Pract

    Association between liver fibrosis and decreased myocardial mechano-energetic efficiency in individuals with different degree of glucose tolerance

    Cross-sectional study

  37. Int J Obes (Lond)

    Genetically predicted visceral adipose tissue and risk of nine non-tumour gastrointestinal diseases: evidence from a Mendelian randomization study

    Research article

  38. Diabetes Res Clin Pract

    Hypertriglyceridemic waist phenotype, hypertriglyceridemic waist-to-height ratio phenotype and abnormal glucose metabolism in adolescents

    Cross-sectional study

  39. Diabetes Obes Metab

    Burden of liver complications related to non‐alcoholic fatty liver disease in China from 2005 to 2019: Observations from the Global Burden of Disease Study, 2019

    Secondary analysis

  40. Obesity (Silver Spring)

    Hepatic and serum branched‐chain fatty acid profile in patients with nonalcoholic fatty liver disease: A case–control study

    Case-control study

All 460 Briefs in ExploreShowing Briefs 401–440 of 460, newest first